Qube Research & Technologies (QRT)
NVCT icon

Qube Research & Technologies (QRT)’s Nuvectis Pharma NVCT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,594
Closed -$166K – 3757
2024
Q4 		$166K Buy
30,594
+8,161
+36% +$51.1K ﹤0.01% 2882
2024
Q3 		$141K Buy
22,433
+14,455
+181% +$95.1K ﹤0.01% 2681
2024
Q2 		$50.5K Buy
+7,978
New +$54.2K ﹤0.01% 2738

Other funds holding NVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $473M AUM 18.73% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVCT Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Nuvectis Pharma (NVCT) in Q1 2025, closing a stake of 30,594 shares — an estimated $166K sold.

Qube Research & Technologies (QRT) first reported a position in NVCT in Q2 2024 and held it in 3 quarters. The position peaked at $166K in Q4 2024. 33 funds tracked by Wall St. Rank hold NVCT as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Nuvectis Pharma position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 30,594 Nuvectis Pharma shares in Q1 2025, an estimated $166K.
  • Qube Research & Technologies (QRT) first reported a position in Nuvectis Pharma in Q2 2024 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Nuvectis Pharma position peaked at $166K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.